A Study of Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer
NCT:NCT07575854 · NOT_YET_RECRUITING
广告
NCT编号NCT07575854
状态NOT_YET_RECRUITING
开始日期2026-10-01
完成时间2029-04-01
SponsorCentre Georges Francois Leclerc (OTHER)
First posted
Last updated
简要摘要
This is a prospective, interventional, open-label, single-arm, multicenter pilot study evaluating the safety, tolerability and maximum tolerated dose (MTD) of splenic Selective Internal Radiation Therapy (SIRT) using TheraSphere in adult patietns with gastrointestinal cancer and chemotherapy-induced thrombocytopenia with splenomegaly
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。